In a remarkable financial turn, Torrent Pharmaceuticals has disclosed a staggering 30% rise in after-tax profit for the September quarter, reaching ₹591 crore. This impressive growth is attributed to thriving sales in various markets, which escalated their total revenue to ₹3,302 crore.
​In a remarkable financial turn, Torrent Pharmaceuticals has disclosed a staggering 30% rise in after-tax profit for the September quarter, reaching ₹591 crore. This impressive growth is attributed to thriving sales in various markets, which escalated their total revenue to ₹3,302 crore. by Soban News (international And National News)
